{
    "en_vn": {
        "data": {
            "content": null,
            "word": "dyskinesia"
        }
    },
    "en_en": {
        "data": {
            "content": "<div class=\"dict--title\">Anh - Anh</div><div class=\"dict--content\"><k>dyskinesia</k><blockquote><cclass>[<cclass>\u02ccd\u026ask\u026a'ni:zi\u0259<cclass>, <cclass>-k\u028c\u026a-<cclass>]</cclass></cclass></cclass></cclass></cclass></blockquote><blockquote>\u25a0 <cclass>noun <cclass>Medicine abnormality or impairment of voluntary movement. </cclass></cclass></blockquote><blockquote/><blockquote><b><cclass>Origin</cclass></b></blockquote><blockquote>C18: from <kref>dys-</kref> + Gk <i>kin\u0113sis</i> 'motion'. </blockquote></div>",
            "word": "dyskinesia"
        }
    },
    "synonyms": {
        "data": {
            "content": null,
            "word": "dyskinesia"
        }
    },
    "grammar": {
        "data": {
            "content": null,
            "word": "dyskinesia"
        }
    },
    "specialist": {
        "data": {
            "content": "<div class=\"dict--title\">T\u1eeb \u0111i\u1ec3n K\u1ef9 thu\u1eadt (EN)</div><div class=\"dict--content\"><table cellspacing=\"0\" cellpadding=\"0\" border=\"0\"><tbody><tr><td/><td><b><font color=\"#1a76bf\">L\u0129nh v\u1ef1c:</font></b><font color=\"#666699\"> y h\u1ecdc</font></td></tr></tbody></table><table cellspacing=\"0\" cellpadding=\"0\" border=\"0\"><tbody><tr><td/><td><font color=\"#999\">\u25a0</font><font>\u00a0r\u1ed1i lo\u1ea1n v\u1eadn \u0111\u1ed9ng</font></td></tr></tbody></table></div>",
            "word": "dyskinesia"
        }
    },
    "sentences": [
        {
            "en": "It also causes abnormalities of movement, especially dystonias, <em>dyskinesia</em>, and Parkinsonism.",
            "vi": "N\u00f3 c\u0169ng g\u00e2y ra c\u1eed \u0111\u1ed9ng b\u1ea5t th\u01b0\u1eddng \u0111\u1eb7c bi\u1ec7t ch\u1ee9ng lo\u1ea1n tr\u01b0\u01a1ng l\u1ef1c, lo\u1ea1n v\u1eadn \u0111\u1ed9ng v\u00e0 b\u1ec7nh parkinson."
        },
        {
            "en": "Gene therapy 'treats' Parkinson's disease      Treating Parkinson's disease with gene therapy has been shown to be successful in clinical trials for the first time, say US researchers. The illness causes uncontrolled shaking, stiffness and slow movement as part of the brain dies. The small study in The Lancet Neurology used a virus to add genes to brain cells, which resulted in reduced symptoms for half of patients. Parkinson's UK welcomed the study, but said further research was needed. The disease affects 120,000 people in the UK, mostly in the over-50s. There is no cure, although drugs and deep brain stimulation have been shown to reduce symptoms.  Gene treatment Patients with Parkinson's have reduced levels of a chemical - GABA - in part of the brain known as the subthalamic nucleus. The researchers created a virus which \"infects\" cells with a gene to increasing GABA production. In the trial, 22 patients had the virus injected into their brains while 23 patients had \"sham surgery\", to make them think they had the virus injected. Their motor function was then scored over six months. Patients who had gene therapy showed a 23.1% improvement in their motor score, those with sham surgery improved by 12.7%. The report's authors say this \"offers a novel alternative to conventional pharmacological or surgical treatment\" and that it \"shows the promise of gene therapy for other neurological disorders.\" Professor Nicholas Mazarakis, who is a specialist in gene therapy at Imperial College London, told the BBC that the positive result was \"very encouraging.\" He added: \"This result should be taken with some caution though, as it constitutes a rather small mean improvement, only 10.4%, in the clinical rating scale motor scores between those patients receiving the gene therapy and the placebo group.\" In addition the absence of significant improvements in other secondary outcome measures such as <em>dyskinesia</em> and quality of life between the two groups, warrants further long-term evaluation of this treatment in more patients.\" There have been concerns about the safety of gene therapy. In 1999, Jesse Gelsinger died during a trial in the US and there were cases of leukaemia after treatment in France. The authors say this procedure is safe. Dr Michelle Gardner, research development manager at Parkinson's UK, said: \"This research shows the promise of gene therapy for neurological conditions like Parkinson's, but further research is still needed.  \"We still don't know for how long the benefits of this treatment may last, or whether there may be long-term problems due to introducing viruses into the brain.  \"In addition, any new treatment must be shown to be more effective than those currently available for Parkinson's, which this treatment has not yet been shown to do.\"",
            "vi": "Li\u1ec7u ph\u00e1p gien \u2018tr\u1ecb\u2019 b\u1ec7nh li\u1ec7t rung    \u0110i\u1ec1u tr\u1ecb b\u1ec7nh li\u1ec7t rung b\u1eb1ng li\u1ec7u ph\u00e1p gien \u0111\u00e3 t\u1ecf ra th\u00e0nh c\u00f4ng trong c\u00e1c cu\u1ed9c th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng l\u1ea7n \u0111\u1ea7u ti\u00ean, c\u00e1c nh\u00e0 nghi\u00ean c\u1ee9u c\u1ee7a Hoa K\u1ef3 n\u00f3i.  B\u1ec7nh n\u00e0y l\u00e0m cho c\u1eed \u0111\u1ed9ng ch\u1eadm ch\u1ea1p, c\u1ee9ng \u0111\u01a1 v\u00e0 rung kh\u00f4ng k\u1ec1m ch\u1ebf \u0111\u01b0\u1ee3c, do n\u00e3o ch\u1ebft.  Nghi\u00ean c\u1ee9u nh\u1ecf tr\u00ean The Lancet Neurology s\u1eed d\u1ee5ng vi-ru\u0301t \u0111\u1ec3 \u0111\u01b0a gien v\u00e0o t\u1ebf b\u00e0o n\u00e3o, d\u1eabn \u0111\u1ebfn k\u1ebft qu\u1ea3 l\u00e0 m\u1ed9t n\u1eeda b\u1ec7nh nh\u00e2n \u0111\u00e3 gi\u1ea3m tri\u1ec7u ch\u1ee9ng.  Hi\u1ec7p h\u1ed9i b\u1ec7nh li\u1ec7t rung c\u1ee7a V\u01b0\u01a1ng qu\u1ed1c Anh vui m\u1eebng v\u1ec1 nghi\u00ean c\u1ee9u n\u00e0y, nh\u01b0ng h\u1ecd n\u00f3i r\u1eb1ng c\u1ea7n ph\u1ea3i nghi\u00ean c\u1ee9u th\u00eam n\u1eefa.  B\u1ec7nh n\u00e0y \u1ea3nh h\u01b0\u1edfng t\u1edbi 120.000 ng\u01b0\u1eddi V\u01b0\u01a1ng qu\u1ed1c Anh, h\u1ea7u h\u1ebft \u1edf nh\u1eefng ng\u01b0\u1eddi tr\u00ean 50 tu\u1ed5i.  Ch\u01b0a c\u00f3 thu\u1ed1c ch\u1eefa, du\u0300 r\u1eb1ng c\u00e1c lo\u1ea1i thu\u1ed1c v\u00e0 ph\u01b0\u01a1ng ph\u00e1p k\u00edch th\u00edch n\u00e3o s\u00e2u t\u1ecf ra \u0111\u00e3 l\u00e0m gi\u1ea3m tri\u1ec7u ch\u1ee9ng.  \u0110i\u1ec1u tr\u1ecb b\u1eb1ng gien C\u00e1c b\u1ec7nh nh\u00e2n b\u1ecb li\u1ec7t rung \u0111\u00e3 gi\u1ea3m m\u1ee9c ho\u00e1 ch\u1ea5t - GABA \u2013 trong ph\u1ea7n n\u00e3o \u0111\u01b0\u1ee3c g\u1ecdi l\u00e0 nh\u00e2n d\u01b0\u1edbi \u0111\u1ed3i.  C\u00e1c nh\u00e0 nghi\u00ean c\u1ee9u \u0111\u00e3 t\u1ea1o ra m\u1ed9t lo\u1ea1i vi-ru\u0301t \"l\u00e2y nhi\u1ec5m\" t\u1ebf b\u00e0o b\u1eb1ng gien \u0111\u1ec3 l\u00e0m t\u0103ng kh\u1ea3 n\u0103ng t\u1ea1o GABA.  Trong cu\u1ed9c th\u1eed nghi\u1ec7m, c\u00f3 22 b\u1ec7nh nh\u00e2n \u0111\u01b0\u1ee3c ti\u00eam vi-ru\u0301t v\u00e0o n\u00e3o trong khi 23 b\u1ec7nh nh\u00e2n kh\u00e1c \u0111\u01b0\u1ee3c \"ph\u1eabu thu\u1eadt gi\u1ea3\", \u0111\u1ec3 t\u1ea1o cho h\u1ecd c\u1ea3m gi\u00e1c l\u00e0 h\u1ecd \u0111\u00e3 \u0111\u01b0\u1ee3c ti\u00eam vi-ru\u0301t.  Sau \u0111\u00f3 ch\u1ee9c n\u0103ng d\u00e2y th\u1ea7n kinh v\u1eadn \u0111\u1ed9ng c\u1ee7a h\u1ecd \u0111\u01b0\u1ee3c ghi nh\u1eadn l\u1ea1i trong s\u00e1u th\u00e1ng.  C\u00e1c b\u1ec7nh nh\u00e2n \u0111\u01b0\u1ee3c ch\u1eefa tr\u1ecb b\u1eb1ng li\u1ec7u ph\u00e1p gien \u0111\u00e3 c\u1ea3i thi\u1ec7n \u0111\u01b0\u1ee3c 23,1% trong k\u1ebft qu\u1ea3 ghi nh\u1eadn v\u1ec1 d\u00e2y th\u1ea7n kinh v\u1eadn \u0111\u1ed9ng c\u1ee7a h\u1ecd, c\u00f2n c\u00e1c b\u1ec7nh nh\u00e2n \u0111\u01b0\u1ee3c gi\u1ea3i ph\u1eabu gi\u1ea3 ch\u1ec9 c\u1ea3i thi\u1ec7n \u0111\u01b0\u1ee3c 12,7%.  T\u00e1c gi\u1ea3 c\u1ee7a b\u1ea3n b\u00e1o c\u00e1o n\u00f3i r\u1eb1ng \u0111i\u1ec1u n\u00e0y \"\u0111\u01b0a ra m\u1ed9t s\u1ef1 l\u1ef1a ch\u1ecdn m\u1edbi thay th\u1ebf cho c\u00e1ch \u0111i\u1ec1u tr\u1ecb b\u1eb1ng thu\u1ed1c hay ph\u1eabu thu\u1eadt th\u00f4ng th\u01b0\u1eddng\" v\u00e0 n\u00f3 \"cho th\u1ea5y li\u1ec7u ph\u00e1p gien \u0111\u1ea7y h\u1ee9a h\u1eb9n cho c\u00e1c r\u1ed1i lo\u1ea1n kh\u00e1c v\u1ec1 th\u1ea7n kinh.\" Gi\u00e1o s\u01b0 Nicholas Mazarakis, chuy\u00ean gia v\u1ec1 li\u1ec7u ph\u00e1p gien t\u1ea1i \u0110\u1ea1i h\u1ecdc Ho\u00e0ng gia Lu\u00e2n \u0110\u00f4n, n\u00f3i v\u1edbi BBC r\u1eb1ng k\u1ebft qu\u1ea3 kh\u1ea3 quan n\u00e0y \"r\u1ea5t \u0111\u00e1ng kh\u00edch l\u1ec7.\" \u00d4ng n\u00f3i th\u00eam: \"Tuy v\u1eady, k\u1ebft qu\u1ea3 n\u00e0y n\u00ean \u0111\u01b0\u1ee3c \u1ee9ng d\u1ee5ng m\u1ed9t c\u00e1ch th\u1eadn tr\u1ecdng, v\u00ec n\u00f3 ch\u1ec9 c\u1ea3i thi\u1ec7n \u0111\u01b0\u1ee3c m\u1ed9t m\u1ee9c \u0111\u1ed9 kh\u00e1 nh\u1ecf, ch\u1ec9 10,4%, trong c\u00e1c ghi nh\u1eadn v\u1ec1 d\u00e2y th\u1ea7n kinh v\u1eadn \u0111\u1ed9ng trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng \u1edf c\u00e1c b\u1ec7nh nh\u00e2n \u0111\u01b0\u1ee3c ch\u1eefa tr\u1ecb b\u1eb1ng li\u1ec7u ph\u00e1p gien v\u00e0 nh\u00f3m du\u0300ng thu\u1ed1c tr\u1ea5n an.\" Ngo\u00e0i ra, kh\u00f4ng c\u00f3 c\u1ea3i ti\u1ebfn \u0111\u00e1ng k\u1ec3 trong bi\u1ec7n ph\u00e1p t\u00e1c \u0111\u1ed9ng ph\u1ee5 kh\u00e1c nh\u01b0 l\u00e0 ch\u1ee9ng lo\u1ea1n v\u1eadn \u0111\u1ed9ng v\u00e0 ch\u1ea5t l\u01b0\u1ee3ng s\u1ed1ng gi\u1eefa hai nh\u00f3m, cho ph\u00e9p \u0111\u00e1nh gi\u00e1 l\u00e2u d\u00e0i c\u00e1ch \u0111i\u1ec1u tr\u1ecb n\u00e0y cho th\u00eam nhi\u1ec1u b\u1ec7nh nh\u00e2n.\" C\u00f3 s\u1ef1 lo ng\u1ea1i v\u1ec1 an to\u00e0n c\u1ee7a li\u1ec7u ph\u00e1p gien. V\u00e0o n\u0103m 1999, Jesse Gelsinger \u0111\u00e3 ch\u1ebft trong m\u1ed9t cu\u1ed9c th\u1eed nghi\u1ec7m \u1edf Hoa K\u1ef3 v\u00e0 c\u00f3 c\u00e1c tr\u01b0\u1eddng h\u1ee3p b\u1ecb ung th\u01b0 m\u00e1u sau khi \u0111\u01b0\u1ee3c \u0111i\u1ec1u tr\u1ecb \u1edf Ph\u00e1p.  C\u00e1c t\u00e1c gi\u1ea3 n\u00f3i r\u1eb1ng ph\u01b0\u01a1ng\u00a0 pha\u0300p n\u00e0y an to\u00e0n.  Ti\u1ebfn s\u0129 Michelle Gardner, gi\u00e1m \u0111\u1ed1c ph\u00e1t tri\u1ec3n nghi\u00ean c\u1ee9u t\u1ea1i Hi\u1ec7p h\u1ed9i b\u1ec7nh li\u1ec7t rung c\u1ee7a V\u01b0\u01a1ng qu\u1ed1c Anh n\u00f3i: \"Nghi\u00ean c\u1ee9u n\u00e0y cho th\u1ea5y li\u1ec7u ph\u00e1p gien \u0111\u1ea7y h\u1ee9a h\u1eb9n cho c\u00e1c b\u1ec7nh th\u1ea7n kinh nh\u01b0 b\u1ec7nh li\u1ec7t rung, nh\u01b0ng cu\u0303ng c\u1ea7n ph\u1ea3i nghi\u00ean c\u1ee9u th\u00eam n\u1eefa.  \"Chu\u0301ng ta v\u1eabn ch\u01b0a bi\u1ebft l\u1ee3i \u00edch c\u1ee7a vi\u1ec7c \u0111i\u1ec1u tr\u1ecb n\u00e0y c\u00f3 th\u1ec3 k\u00e9o d\u00e0i bao l\u00e2u, ho\u1eb7c li\u1ec7u c\u00f3 x\u1ea3y ra nh\u1eefng v\u1ea5n \u0111\u1ec1 l\u00e2u d\u00e0i v\u00ec \u0111\u01b0a vi-ru\u0301t v\u00e0o n\u00e3o hay kh\u00f4ng.  \"H\u01a1n n\u1eefa, b\u1ea5t k\u1ef3 c\u00e1ch \u0111i\u1ec1u tr\u1ecb m\u1edbi n\u00e0o ph\u1ea3i t\u1ecf ra c\u00f3 hi\u1ec7u qu\u1ea3 h\u01a1n c\u00e1c c\u00e1ch \u0111i\u1ec1u tr\u1ecb b\u1ec7nh li\u1ec7t rung hi\u1ec7n th\u1eddi, nh\u01b0ng c\u00e1ch \u0111i\u1ec1u tr\u1ecb n\u00e0y l\u1ea1i ch\u01b0a ch\u1ee9ng minh \u0111\u01b0\u1ee3c nh\u01b0 v\u1eady.\" http://www.bbc.co.uk/news/health-12758230"
        }
    ],
    "suggestions": []
}